Efficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) Status
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bert H O'Neil, MD
Aptium Oncology Gastrointestinal Cancer Consortium
Principal Investigator - Jane Robertson, BSc, MBCHB, MD
AstraZeneca
Study Director - Lawrence P Leichman, MD
Aptium Oncology Gastrointestinal Cancer Consortium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Los Angeles, California, United States
- Research Site
Palm Springs, California, United States
- Research Site
Aurora, Colorado, United States
- Research Site
Newark, Delaware, United States
- Research Site
New York, New York, United States
- Research Site
Philadelphia, Pennsylvania, United States
- Research Site
Nashville, Tennessee, United States
- Research Site
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2009
- Primary completion
- 31 Mar 2012
- Completion
- 31 Mar 2012
- Last update posted
- 9 Nov 2016
- Registered enrollment
- 33
- Registry id
- NCT00912743
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.